Ying Hou

Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis

Jie Yu, Bingling Zhong, Lin Zhao et al. · Drug Resistance Updates · 2023 · 73 citations

Life Sciences, Molecular Biology, Oncology +14

Induction of an MLKL mediated non-canonical necroptosis through reactive oxygen species by tanshinol A in lung cancer cells

Xin Liu, Hongwei Gao, Ying Hou et al. · Biochemical Pharmacology · 2019 · 56 citations

Life Sciences, Cell Biology, Oncology +14

Dihydronortanshinone, a natural product, alleviates LPS-induced inflammatory response through NF-κB, mitochondrial ROS, and MAPK pathways

Xiaxia Wu, Hongwei Gao, Ying Hou et al. · Toxicology and Applied Pharmacology · 2018 · 48 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Inhibition of Lung Cancer by 2-Methoxy-6-Acetyl-7-Methyljuglone Through Induction of Necroptosis by Targeting Receptor-Interacting Protein 1

Wen Sun, Jie Yu, Hongwei Gao et al. · Antioxidants and Redox Signaling · 2018 · 40 citations

Medicine, Oncology, Pharmacology +17

2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H: Quinone oxidoreductase 1 (NQO1)

Jie Yu, Bingling Zhong, Long Jin et al. · Free Radical Biology and Medicine · 2020 · 38 citations

Medicine, Cancer Biology, Oncology +14